Human Metapneumovirus and Human Parainfluenza Infection
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Human Metapneumovirus and Human Parainfluenza Infection trials may be worth asking aboutClinical trial pipeline · Data from ClinicalTrials.gov
See which Human Metapneumovirus and Human Parainfluenza Infection trials may be worth asking aboutNorth America
Europe
Asia-Pacific
Rest of World
Trials may have sites in multiple countries. Filtering shows any trial with at least one site in the selected country.
The purpose of this research study is to try to see whether an experimental drug, PUL 042 Inhalation Solution (PUL 042), is effective in reducing the severity o…
The goal of this Phase 2 study is to assess about the safety, antiviral biomarker responses and efficacy of SNG001 when given to patients requiring invasive mec…
This phase 1/2 study will evaluate the safety, reactogenicity and immunogenicity of SCB-1022 and SCB-1033 compared to SCB-1019T (Parts 1 and 2) or Placebo (Part…
The purpose of this phase 1 study is to evaluate whether the vaccine is safe and can help the body to develop germ fighting agents called "antibodies" (immunoge…